Cost Of Revenue - Syneos Health Inc (F:8IN) - Alpha Spread
S

Syneos Health Inc
F:8IN

Watchlist Manager
Syneos Health Inc
F:8IN
Watchlist
Price: 40 EUR Market Closed
Market Cap: 4.1B EUR
Have any thoughts about
Syneos Health Inc?
Write Note

Syneos Health Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Syneos Health Inc
Cost of Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Syneos Health Inc
F:8IN
Cost of Revenue
-$4.2B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25.1B
CAGR 3-Years
-10%
CAGR 5-Years
-13%
CAGR 10-Years
-11%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$9.1B
CAGR 3-Years
6%
CAGR 5-Years
-5%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$2.9B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.8B
CAGR 3-Years
-5%
CAGR 5-Years
-7%
CAGR 10-Years
-10%

See Also

What is Syneos Health Inc's Cost of Revenue?
Cost of Revenue
-4.2B USD

Based on the financial report for Jun 30, 2023, Syneos Health Inc's Cost of Revenue amounts to -4.2B USD.

What is Syneos Health Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-6%

Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for Syneos Health Inc have been -6% over the past three years , -6% over the past five years .

Back to Top